Colorectal Cancer Diagnostics Market Scope And Analysis

  • Report Code : TIPRE00013454
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 213
Buy Now

Colorectal Cancer Diagnostics Market Scope and Analysis by 2028

Buy Now

Colorectal Cancer Diagnostics Market Report Colorectal Cancer Diagnostics Market Size and Share Colorectal Cancer Diagnostics Market Scope and Analysis

Colorectal Cancer Diagnostics Market Report Scope

Report Attribute Details
Market size in 2022 US$ 10.37 Billion
Market Size by 2028 US$ 17 Billion
Global CAGR (2022 - 2028) 8.7%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Modality
  • Imaging Tests
  • Stool Based Tests
By End User
  • Hospitals
  • Diagnostic Laboratories
  • Cancer Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medtronic Plc
  • Illumina Inc
  • Clinical Genomics Technologies Pty Ltd
  • EDP Biotech Corp
  • Epigenomics AG
  • F Hoffmann La Roche Ltd
  • Quest Diagnostics Inc
  • Novigenix SA
  • Siemens Healthineers AG

    • Company Profiles

    • Medtronic Plc
    • Illumina Inc
    • Clinical Genomics Technologies Pty Ltd
    • EDP Biotech Corp
    • Epigenomics AG
    • F. Hoffmann-La Roche Ltd
    • Quest Diagnostics Inc
    • Novigenix SA
    • Siemens Healthineers AG
    • Bruker Corp
    • Eiken Chemical Co., Ltd.